Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$10.67 - $14.43 $237,364 - $321,009
22,246 New
22,246 $313,000
Q4 2022

Mar 06, 2023

BUY
$7.95 - $9.48 $18,722 - $22,325
2,355 Added 16.82%
16,356 $148,000
Q3 2022

Nov 02, 2022

SELL
$6.86 - $11.95 $87,471 - $152,374
-12,751 Reduced 47.66%
14,001 $112,000
Q2 2022

Aug 12, 2022

BUY
$7.38 - $10.4 $2,479 - $3,494
336 Added 1.27%
26,752 $200,000
Q4 2021

Feb 14, 2022

BUY
$7.9 - $10.19 $53,980 - $69,628
6,833 Added 34.89%
26,416 $211,000
Q3 2021

Nov 12, 2021

BUY
$8.38 - $10.18 $61,886 - $75,179
7,385 Added 60.54%
19,583 $190,000
Q2 2021

Aug 10, 2021

BUY
$9.9 - $11.56 $101,257 - $118,235
10,228 Added 519.19%
12,198 $120,000
Q4 2020

Feb 12, 2021

BUY
$8.61 - $11.04 $1,911 - $2,450
222 Added 12.7%
1,970 $18,000
Q3 2020

Nov 13, 2020

SELL
$8.57 - $12.69 $2,973 - $4,403
-347 Reduced 16.56%
1,748 $15,000
Q2 2020

Aug 12, 2020

SELL
$8.12 - $13.12 $66,299 - $107,124
-8,165 Reduced 79.58%
2,095 $26,000
Q1 2020

May 12, 2020

BUY
$6.69 - $13.45 $1,672 - $3,362
250 Added 2.5%
10,260 $92,000
Q4 2019

Feb 07, 2020

BUY
$6.53 - $10.72 $57,862 - $94,989
8,861 Added 771.19%
10,010 $98,000
Q3 2019

Nov 12, 2019

SELL
$6.16 - $9.6 $628 - $979
-102 Reduced 8.15%
1,149 $8,000
Q2 2019

Aug 09, 2019

SELL
$8.12 - $15.72 $3,524 - $6,822
-434 Reduced 25.76%
1,251 $11,000
Q1 2019

May 10, 2019

BUY
$15.58 - $20.01 $10,329 - $13,266
663 Added 64.87%
1,685 $27,000
Q4 2018

Feb 12, 2019

SELL
$14.59 - $23.84 $5,836 - $9,536
-400 Reduced 28.13%
1,022 $16,000
Q1 2018

May 09, 2018

BUY
$16.68 - $22.07 $23,718 - $31,383
1,422 New
1,422 $24,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Rockefeller Capital Management L.P. Portfolio

Follow Rockefeller Capital Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Rockefeller Capital Management L.P. with notifications on news.